ATE62507T1 - Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert. - Google Patents

Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.

Info

Publication number: ATE62507T1
Authority: AT; Austria
Prior art keywords: characterization; sequence encoding; molecular cloning; gene sequence; encoding human
Prior art date: 1982-12-13

Application number

AT83307553T

Other languages

English (en)

Inventor

Peter John Hudson

Hugh David Niall

Geoffrey William Tregear

Original Assignee

Florey Howard Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-12-13

Filing date

1983-12-12

Publication date

1991-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3769889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE62507(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-12-12 Application filed by Florey Howard Inst filed Critical Florey Howard Inst

1991-04-15 Application granted granted Critical

1991-04-15 Publication of ATE62507T1 publication Critical patent/ATE62507T1/de

Links

BJRCFZKVYNDCJE-WBSNEMHCSA-N 99489-95-9 Chemical compound C([C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N2)[C@@H](C)CC)=O)CSSC[C@@H](C(NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC1=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C1=CC=C(O)C=C1 BJRCFZKVYNDCJE-WBSNEMHCSA-N 0.000 title 1
238000012512 characterization method Methods 0.000 title 1
238000010369 molecular cloning Methods 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
101001091088 Homo sapiens Prorelaxin H2 Proteins 0.000 abstract 2
102000049116 human RLN2 Human genes 0.000 abstract 2
238000000034 method Methods 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
General Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Reproductive Health (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT83307553T 1982-12-13 1983-12-12 Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert. ATE62507T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPF724782		1982-12-13
EP83307553A EP0112149B1 (de)	1982-12-13	1983-12-12	Molekulare Klonierung und Charakterisierung einer anderen Gensequenz die für menschliches Relaxin kodiert

Publications (1)

Publication Number	Publication Date
ATE62507T1 true ATE62507T1 (de)	1991-04-15

Family

ID=3769889

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT88110103T ATE90360T1 (de)	1982-12-13	1983-12-12	Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.
AT83307553T ATE62507T1 (de)	1982-12-13	1983-12-12	Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT88110103T ATE90360T1 (de)	1982-12-13	1983-12-12	Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.

Country Status (14)

Country	Link
US (1)	US4758516A (de)
EP (2)	EP0303033B1 (de)
JP (3)	JP2545055B2 (de)
KR (1)	KR940002536B1 (de)
AT (2)	ATE90360T1 (de)
CA (1)	CA1220735A (de)
DE (1)	DE3382249D1 (de)
DK (2)	DK171684B1 (de)
ES (6)	ES8602133A1 (de)
HU (1)	HU197767B (de)
IE (1)	IE63902B1 (de)
IL (1)	IL70414A (de)
NZ (1)	NZ206534A (de)
ZA (1)	ZA839231B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0101309B1 (de) *	1982-08-12	1991-01-16	Howard Florey Institute Of Experimental Physiology And Medicine	Molekulare Klonierung und Charakterisierung der das menschliche Relaxin kodierenden Gen-Sequenz
US5179195A (en) *	1982-12-13	1993-01-12	Howard Florey Institute Of Experimental Physiology And Medicine	Human relaxin polypeptides
US4835251A (en) *	1986-06-23	1989-05-30	Genetech, Inc.	Method of chain combination
NZ221789A (en) *	1986-09-12	1991-05-28	Genentech Inc	Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it
AU626840B2 (en) *	1988-02-26	1992-08-13	Genentech Inc.	Human relaxin formulation
CA2051375C (en) *	1989-05-04	2000-09-12	Dennis J. Henner	Process and compositions for the isolation of human relaxin
US5089419A (en) *	1989-08-07	1992-02-18	International Canine Genetics	Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US5478807A (en) *	1991-08-19	1995-12-26	Genentech, Inc.	Use of relaxin in the treatment of bradycardia
US5166191A (en) *	1991-08-19	1992-11-24	Genentech, Inc.	Use of relaxin in cardiovascular therapy
AU3123393A (en) *	1991-10-28	1993-06-07	Board Of Regents, The University Of Texas System	A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid
US6348327B1 (en)	1991-12-06	2002-02-19	Genentech, Inc.	Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
WO1995000645A2 (en) *	1993-06-21	1995-01-05	Genentech, Inc.	Process for producing relaxin
US20050032683A1 (en)	2000-10-04	2005-02-10	Amento Edward P.	Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040006205A1 (en) *	2001-04-03	2004-01-08	Li Li	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002324727A1 (en) *	2001-08-17	2003-03-03	The Board Of Trustees Of The Leland Stanford Junior University	Mammalian relaxin receptors
AU2003903124A0 (en) *	2003-06-20	2003-07-10	Mark Del Borgo	Analogues of heteromeric proteins
JP4836942B2 (ja) *	2004-04-30	2011-12-14	コーセラ，インコーポレイテッド	リラキシンの調節による胎仔の発育の制御のための方法および組成物
US20060052304A1 (en) *	2004-09-02	2006-03-09	Bas Medical, Inc.	Method for remodeling bone and related sutures
RU2501573C2 (ru) *	2008-05-16	2013-12-20	Кортера, Инк.	Способ предупреждения преждевременных родов
GR1006941B (el)	2009-06-01	2010-08-27	Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras),	Πεπτιδικη συνθεση (peptide synthesis)
US8389475B2 (en)	2009-08-10	2013-03-05	The Board Of Trustees Of The Leland Stanford Junior University	Relaxin analogs
EA030886B1 (ru)	2010-08-17	2018-10-31	Амбркс, Инк.	Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение
RU2014103288A (ru) *	2011-07-01	2015-08-10	Байер Интеллектчуал Проперти Гмбх	Слитые полипептиды релаксина и их применение
EP2630964A1 (de)	2012-02-22	2013-08-28	Immundiagnostik AG	Verfahren und Medikation zur Behandlung von Patienten mit Risiko für Prädiabetes und Typ-2-Diabetes
EP3068891A1 (de)	2013-11-13	2016-09-21	Aequus Biopharma Inc.	Manipulierte glycoproteine und verwendungen davon
EP2946788A1 (de)	2014-05-23	2015-11-25	Immundiagnostik AG	Verfahren und Zusammensetzung zur Behandlung von Herzversagen mit erhaltener Austreibungsfraktion
IL263079B2 (en)	2016-05-18	2024-05-01	Modernatx Inc	Polynucleotides encoding relaxin
PE20191716A1 (es)	2017-02-08	2019-12-05	Bristol Myers Squibb Co	Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4468464A (en) *	1974-11-04	1984-08-28	The Board Of Trustees Of The Leland Stanford Junior University	Biologically functional molecular chimeras
GR70279B (de) *	1979-09-12	1982-09-03	Univ California
US4267101A (en) *	1980-02-01	1981-05-12	Serono Laboratories Inc.	Process for obtaining human relaxin from fetal membranes
EP0068375A3 (de) *	1981-06-22	1983-04-13	G.D. Searle & Co.	Rekombinante DNS Technik zur Herstellung von Relaxin
IE55479B1 (en) *	1982-02-12	1990-09-26	Florey Howard Inst	Molecular cloning and characterization of the gene sequence coding for porcine relaxin
EP0101309B1 (de) *	1982-08-12	1991-01-16	Howard Florey Institute Of Experimental Physiology And Medicine	Molekulare Klonierung und Charakterisierung der das menschliche Relaxin kodierenden Gen-Sequenz

1983
- 1983-12-09 IL IL70414A patent/IL70414A/xx not_active IP Right Cessation
- 1983-12-09 NZ NZ206534A patent/NZ206534A/en unknown
- 1983-12-12 EP EP88110103A patent/EP0303033B1/de not_active Expired - Lifetime
- 1983-12-12 AT AT88110103T patent/ATE90360T1/de not_active IP Right Cessation
- 1983-12-12 ES ES527964A patent/ES8602133A1/es not_active Expired
- 1983-12-12 ZA ZA839231A patent/ZA839231B/xx unknown
- 1983-12-12 EP EP83307553A patent/EP0112149B1/de not_active Expired - Lifetime
- 1983-12-12 AT AT83307553T patent/ATE62507T1/de not_active IP Right Cessation
- 1983-12-12 CA CA000443049A patent/CA1220735A/en not_active Expired
- 1983-12-12 DE DE8383307553T patent/DE3382249D1/de not_active Expired - Lifetime
- 1983-12-12 IE IE290883A patent/IE63902B1/en not_active IP Right Cessation
- 1983-12-13 DK DK573783A patent/DK171684B1/da not_active IP Right Cessation
- 1983-12-13 JP JP58233744A patent/JP2545055B2/ja not_active Expired - Lifetime
- 1983-12-13 HU HU834243A patent/HU197767B/hu unknown
- 1983-12-13 KR KR1019830005905A patent/KR940002536B1/ko not_active Expired - Lifetime
- 1983-12-13 US US06/560,790 patent/US4758516A/en not_active Expired - Lifetime
1985
- 1985-06-17 ES ES544293A patent/ES8802249A1/es not_active Expired
1986
- 1986-02-17 ES ES552093A patent/ES8708016A1/es not_active Expired
- 1986-02-17 ES ES552095A patent/ES8801373A1/es not_active Expired
- 1986-02-17 ES ES552094A patent/ES8708015A1/es not_active Expired
1987
- 1987-05-11 ES ES557531A patent/ES8801675A1/es not_active Expired
1992
- 1992-11-30 DK DK143492A patent/DK172012B1/da not_active IP Right Cessation
1993
- 1993-03-22 JP JP5061747A patent/JP2677332B2/ja not_active Expired - Lifetime
1994
- 1994-10-26 JP JP6262254A patent/JP2891882B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR940002536B1 (ko)	1994-03-25
DK171684B1 (da)	1997-03-10
ES527964A0 (es)	1985-11-16
EP0112149B1 (de)	1991-04-10
EP0303033A3 (en)	1989-10-25
ES8708016A1 (es)	1987-09-01
ATE90360T1 (de)	1993-06-15
ES8801373A1 (es)	1987-12-16
DK573783D0 (da)	1983-12-13
DK143492A (da)	1992-11-30
EP0112149A2 (de)	1984-06-27
ES552095A0 (es)	1987-12-16
ES8602133A1 (es)	1985-11-16
EP0303033B1 (de)	1993-06-09
ES544293A0 (es)	1988-04-16
ES8708015A1 (es)	1987-09-01
DK172012B1 (da)	1997-09-15
IE63902B1 (en)	1995-06-14
NZ206534A (en)	1988-05-30
CA1220735A (en)	1987-04-21
DK143492D0 (da)	1992-11-30
JPH07173198A (ja)	1995-07-11
IL70414A (en)	1991-06-10
EP0303033A2 (de)	1989-02-15
ES552094A0 (es)	1987-09-01
DE3382249D1 (de)	1991-05-16
HU197767B (en)	1989-05-29
JP2677332B2 (ja)	1997-11-17
JP2891882B2 (ja)	1999-05-17
ZA839231B (en)	1984-08-29
EP0112149A3 (en)	1985-05-22
IL70414A0 (en)	1984-03-30
US4758516A (en)	1988-07-19
ES8802249A1 (es)	1988-04-16
IE832908L (en)	1984-06-13
JPS59156284A (ja)	1984-09-05
DK573783A (da)	1984-06-14
ES8801675A1 (es)	1988-02-16
ES552093A0 (es)	1987-09-01
JPH06100585A (ja)	1994-04-12
ES557531A0 (es)	1988-02-16
JP2545055B2 (ja)	1996-10-16
KR840007024A (ko)	1984-12-04

Legal Events

Date	Code	Title	Description
1992-01-15	UEP	Publication of translation of european patent specification
2004-03-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE62507T1 (de)	1991-04-15	Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.
FI874819L (fi)	1987-11-02	Human rekombinant endotelcell vaextfaktor.
FI874287A7 (fi)	1988-04-04	Uudet lymfokiinipeptidit.
DE3588149D1 (de)	1997-05-07	Rekombinante DNS-Verfahren und dadurch hergestellte Produkte
DE3382117D1 (de)	1991-02-21	Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
EP0237045A3 (en)	1988-11-02	Dna encoding flagellin and vector having the same
DE3771563D1 (de)	1991-08-29	Ballenzerreisser.
DE3688057D1 (de)	1993-04-22	Halbleitervorrichtung und methode zur herstellung.
DE69013811D1 (de)	1994-12-08	Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
EP0273800A3 (en)	1988-07-20	Hirudine variants, their use and preparation
DE3768459D1 (de)	1991-04-11	Duese zur zufuhr von behandlungsdraht.
FI874123A7 (fi)	1987-09-22	Heptanoyyli-Glu-Asp-Ala-aminohappo -immunostimulantti.
IT8620922A0 (it)	1986-06-26	Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite, utili nel trattamentodi trombosi.
DK0919621T3 (da)	2009-01-19	Human TAK1 og DNA der koder derfor
DE3764206D1 (de)	1990-09-13	Schnittfeste ummantelung fuer seile, gurte, riemen, aufblasbare gegenstaende und aehnliches.
DE3783815D1 (de)	1993-03-11	Poly 1,2,2-trimethyl-1-phenyldisilane und verfahren zur herstellung.
DE69534738D1 (de)	2006-04-06	Leukocyten-aktivierender Faktor
DE3382692D1 (de)	1993-07-15	Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.
DE59002296D1 (de)	1993-09-16	Verfahren zur herstellung von in 4,4'-stellung dihalogenierten oligophenylen.
DE59000336D1 (de)	1992-11-12	Mischung aus mehlsorten und kleie fuer die herstellung von soja-pizza.
IT8822286A0 (it)	1988-10-13	Miscela di caucciu' reticolabile, in particolare vulcanizzabile mediante zolfo.
NO902926L (no)	1990-08-30	Peptid tilsvarende hiv-env 583-599, og analoger derav, samt anvendelser av peptidene.
ATE75255T1 (de)	1992-05-15	Peptid und dafuer kodierendes gen.